• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

SATA

Society for the Advancement of Transplant Anesthesia

  • Home
    • For Authors
  • About SATA
    • Committees
      • Cardiothoracic Transplant Committee
        • Cardiothoracic Transplantation Educational Task Force
      • Quality and Standards Committee
      • Newsletter Committee
      • Pediatric Transplant Committee
      • Vanguard Committee
      • Abdominal Educational Committee
      • Fellowship Committee
      • Research Committee
      • Bylaws Committee
        • SATA Bylaws
  • Membership
    • Join Now
  • Education
    • Meetings & Events
      • Meeting
    • Education Materials
      • Article of the Month
      • Protocols / Recommendations / PBLDs
      • Educational Media
      • Transplant Fellowship Information
      • Archive
  • Research
    • SATA Publications
  • Newsletter
  • Careers
    • Jobs
    • Post a Job
  • Contact
  • Log In

Prevalence and Patterns of Opioid Use Before and After Liver Transplantation

May 18, 2021 By Sergio

Abdominal Organ Transplant Article of the Month

Abstract:

Background. Opioid use in liver transplantation is poorly understood and has potential associated morbidity.

Methods. Using a national data set of employer-based insurance claims, we identified 1257 adults who underwent liver transplantation between December 2009 and February 2015. We categorized patients based on their duration of opioid fills over the year before and after transplant admission as opioid naive/no fills, chronic opioid use (≥120 d supply), and intermittent use (all other use). We calculated risk-adjusted prevalence of peri-transplant opioid fills, assessed changes in opioid use after transplant, and identified correlates of persistent or increased opioid use post-transplant.

Results. Overall, 45% of patients filled ≥1 opioid prescription in the year before transplant (35% intermittent use, 10% chronic). Post-transplant, 61% of patients filled an opioid prescription 0–2 months after discharge, and 21% filled an opioid between 10–12 months after discharge. Among previously opioid-naive patients, 4% developed chronic use post-transplant. Among patients with pre-transplant opioid use, 84% remained intermittent or increased to chronic use, and 73% of chronic users remained chronic users after transplant. Pre-transplant opioid use (risk factor) and hepatobiliary malignancy (protective) were the only factors independently associated with risk of persistent or increased post-transplant opioid use.

Conclusions. Prescription opioid use is common before and after liver transplant, with intermittent and chronic use largely persisting, and a small development of new chronic use post-transplant. To minimize the morbidity of long-term opioid use, it is critical to improve pain management and optimize opioid use before and after liver transplant.

Expert summary by Cara Crouch, MD

This content is for SATA Members only

Login To have access to the Content!

Username:
Password:
Register
Lost your password?

References:

  1. Cron D, Tincopa M, Lee J, Waljee A, Hammoud A, Brummet C, Waljee J, Englesbe M, Sonnenday C. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. Transplantation. 2021; 105(1):100-107
  2. Braun H, Ascher N. Opioid Use and Liver Transplantation. Transplantation. 2021; 105(1):25-26

 

Filed Under: Article of the Month, Education

Reader Interactions

Primary Sidebar

Information for Authors

Upcoming Events

There are no upcoming events at this time.

President’s Message

Tetsuro Sakai MD

Tetsuro Sakai MD, PhD, MHA, FASA

SATA President

Read more

Contact Us

Copyright © 2022 Society for the Advancement of Transplant Anesthesia (SATA) - Powered by: Top Shelf Design